KRISTEN WHITE: Open Payments
NPI 1245394709 · HENDERSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 46 payments from 12 companies in 2025. Trend: 2023 $853 · 2024 $1,148 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $243 |
| AstraZeneca Pharmaceuticals LP | 6 | $199 |
| ABBVIE INC. | 8 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $106 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Exact Sciences Corporation | 3 | $56 |
| Lilly USA, LLC | 2 | $32 |
| Abbott Laboratories | 1 | $26 |
| Genentech, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
Products named: FARXIGA, CAPLYTA, Wegovy, TRELEGY ELLIPTA, Ozempic, UBRELVY, Rybelsus, BREZTRI.
Industry payments across NC — which companies pay providers there.
